A Stock Overview
Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 6/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for A from our risk checks.
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
Agilent Technologies, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$128.57 |
| 52 Week High | US$155.35 |
| 52 Week Low | US$123.48 |
| Beta | 1.07 |
| 11 Month Change | -5.99% |
| 3 Month Change | -8.31% |
| 1 Year Change | 3.69% |
| 33 Year Change | -15.95% |
| 5 Year Change | 58.57% |
| Change since IPO | 200.75% |
Recent News & Updates
Here's Why Agilent Technologies (NYSE:A) Can Manage Its Debt Responsibly
Oct 21
With EPS Growth And More, Agilent Technologies (NYSE:A) Makes An Interesting Case
Sep 23Recent updates
Here's Why Agilent Technologies (NYSE:A) Can Manage Its Debt Responsibly
Oct 21With EPS Growth And More, Agilent Technologies (NYSE:A) Makes An Interesting Case
Sep 23Agilent Technologies' (NYSE:A) Profits May Not Reveal Underlying Issues
Sep 09Agilent: A 'Buy' Due To Growing Biopharma, PFAS, And Semi
Aug 23A Look At The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)
Aug 14Agilent: Making A Move To Ignite Some Growth
Jul 25Agilent Technologies (NYSE:A) Has A Pretty Healthy Balance Sheet
Jul 15Is Agilent A Buy Before Earnings? Examining The Pros And Cons
May 23Should You Investigate Agilent Technologies, Inc. (NYSE:A) At US$154?
May 22Subdued Growth No Barrier To Agilent Technologies, Inc.'s (NYSE:A) Price
May 07These 4 Measures Indicate That Agilent Technologies (NYSE:A) Is Using Debt Reasonably Well
Apr 05Agilent Technologies: Cash Flow Returns On Investments And Conventional All Point To A Hold
Mar 12Agilent Technologies Hit A Homerun
Dec 24Agilent: A Wide Moat Company Expected To Return To Growth In 2024 (Rating Upgrade)
Dec 08Agilent Technologies (NYSE:A) Seems To Use Debt Quite Sensibly
Dec 07Agilent Technologies: Looking Undervalued Heading Into Earnings
Nov 17Estimating The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)
Oct 26Agilent: Dips Into GARP Territory, Shares At A Crucial Spot On The Chart
Sep 26Is It Too Late To Consider Buying Agilent Technologies, Inc. (NYSE:A)?
Sep 08Agilent Technologies (NYSE:A) Seems To Use Debt Quite Sensibly
Aug 21Calculating The Fair Value Of Agilent Technologies, Inc. (NYSE:A)
Jul 23Agilent Technologies - A Wealth Compounder 30% Below Its Highs
Jul 13Here's Why We Think Agilent Technologies (NYSE:A) Might Deserve Your Attention Today
Jul 10What Is Agilent Technologies, Inc.'s (NYSE:A) Share Price Doing?
May 28Agilent Technologies Stock: Starting To Look Appealing
May 25These 4 Measures Indicate That Agilent Technologies (NYSE:A) Is Using Debt Safely
Apr 17Shareholder Returns
| A | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | -4.3% | -7.2% | -1.2% |
| 1Y | 3.7% | 1.2% | 30.4% |
Return vs Industry: A exceeded the US Life Sciences industry which returned 1.2% over the past year.
Return vs Market: A underperformed the US Market which returned 30.4% over the past year.
Price Volatility
| A volatility | |
|---|---|
| A Average Weekly Movement | 3.5% |
| Life Sciences Industry Average Movement | 8.8% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: A has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: A's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 17,400 | Padraig McDonnell | www.agilent.com |
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Agilent Technologies, Inc. Fundamentals Summary
| A fundamental statistics | |
|---|---|
| Market cap | US$36.11b |
| Earnings (TTM) | US$1.41b |
| Revenue (TTM) | US$6.50b |
26.1x
P/E Ratio5.7x
P/S RatioIs A overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A income statement (TTM) | |
|---|---|
| Revenue | US$6.50b |
| Cost of Revenue | US$2.96b |
| Gross Profit | US$3.53b |
| Other Expenses | US$2.12b |
| Earnings | US$1.41b |
Last Reported Earnings
Jul 31, 2024
Next Earnings Date
Nov 25, 2024
| Earnings per share (EPS) | 4.92 |
| Gross Margin | 54.39% |
| Net Profit Margin | 21.75% |
| Debt/Equity Ratio | 49.7% |
How did A perform over the long term?
See historical performance and comparison